regadenoson has been researched along with Hyperemia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 13 (72.22) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Angoulvant, D; Bailly, M; Brana, Q; Courtehoux, M; Metrard, G; Ribeiro, MJ; Thibault, F | 1 |
| Kero, T; Knuuti, J; Lagerqvist, B; Lubberink, M; Pikkarainen, E; Saraste, A; Sörensen, J | 1 |
| Adluru, G; Bieging, ET; Chang, L; DiBella, E; Haider, I; Jensen, L; Likhite, D; McGann, CJ; Shaaban, A; Suksaranjit, P; Wilson, BD | 1 |
| Kaandorp, TAM; Kuijpers, D; Oudkerk, M; van der Harst, P; van Dijk, R; van Dijkman, PRM; Vliegenthart, R | 1 |
| Howe, C; Kumar, G; Lee, JZ; Lee, KS; Low, SW; Nguyen, T; Nyotowidjojo, I; Pinto, D; Singh, N | 1 |
| Clavijo, LC; Doherty, R; Gopal, A; Matthews, RV; Mehra, A; Prasad, A; Shavelle, DM; Somma, K; Vora, H; Zareh, M | 1 |
| Dziuk, M; Kocki, J; Pińkowski, R; Tkaczewski, K | 1 |
| Al-Amoodi, M; Ballany, W; Doukky, R; Mansour, K; Morales Demori, R | 1 |
| Brueren, GR; Lenders, GD; Pijls, NH; Schampaert, S; Tonino, PA; van 't Veer, M; van Nunen, LX; Wijnbergen, I | 1 |
| Amano, T; Doh, JH; Kato, D; Kim, HS; Koo, BK; Kurita, A; Lim, WH; Nam, CW; Oi, M; Park, JJ; Park, KW; Pijls, NH; Takashima, H; Toyofuku, M; van Nunen, L; Waseda, K; Yang, HM | 1 |
| Gould, KL; Johnson, NP | 1 |
| Dilsizian, V; Narula, J | 1 |
| Maddahi, J; Packard, RRS | 1 |
| Buhr, C; Eggebrecht, H; Erbel, R; Gössl, M | 1 |
| Belardinelli, L; Dione, DP; Jadbabaie, F; Mekkaoui, C; Meoli, DF; Purushothaman, K; Sinusas, AJ | 1 |
| Dilsizian, V | 1 |
| Adluru, G; Chen, L; DiBella, EV; Fluckiger, JU; Jiji, R; Kim, TH; Kuppahally, S; Litwin, SE; Matthews, B; McGann, C; Pack, NA; Priester, T | 1 |
| Bhave, NM; Dill, K; Freed, BH; Kolanczyk, D; Lang, RM; Mor-Avi, V; Patel, AR; Yodwut, C | 1 |
3 review(s) available for regadenoson and Hyperemia
| Article | Year |
|---|---|
Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis.
Topics: Administration, Intravenous; Adult; Aged; Cardiac Catheterization; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Male; Middle Aged; Nitroprusside; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Severity of Illness Index; Vasodilator Agents | 2018 |
[A novel way to induce coronary hyperaemia].
Topics: Adenosine; Coronary Angiography; Coronary Stenosis; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Purines; Pyrazoles | 2013 |
Regadenoson in the detection of coronary artery disease.
Topics: Adenosine A2 Receptor Agonists; Animals; Contraindications; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Heart Function Tests; Humans; Hyperemia; Purines; Pyrazoles; Receptor, Adenosine A2A; Structure-Activity Relationship; Time Factors; Vasodilation; Vasodilator Agents | 2008 |
4 trial(s) available for regadenoson and Hyperemia
| Article | Year |
|---|---|
The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
Topics: Adenosine A2 Receptor Agonists; Aminophylline; Cardiotonic Agents; Double-Blind Method; Exercise Test; Female; Humans; Hyperemia; Image Enhancement; Male; Middle Aged; Myocardial Perfusion Imaging; Placebo Effect; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |
Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement.
Topics: Aged; Cardiac Catheterization; Catheterization, Central Venous; Catheterization, Peripheral; Coronary Angiography; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Netherlands; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Vasodilator Agents | 2015 |
The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adult; Body Mass Index; Contrast Media; Coronary Circulation; Drug Dosage Calculations; Female; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Perfusion Imaging; Obesity; Organometallic Compounds; Predictive Value of Tests; Purines; Pyrazoles; Time Factors; Utah; Vasodilator Agents | 2012 |
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
Topics: Adult; Aminophylline; Blood Pressure; Chicago; Contrast Media; Coronary Circulation; Female; Heart Rate; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Recovery of Function; Reference Values; Reproducibility of Results; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left; Young Adult | 2012 |
11 other study(ies) available for regadenoson and Hyperemia
| Article | Year |
|---|---|
Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.
Topics: Coronary Circulation; Dipyridamole; Humans; Hyperemia; Myocardial Perfusion Imaging; Purines; Pyrazoles; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2022 |
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease.
Topics: Adenosine; Arteries; Coronary Artery Disease; Coronary Circulation; Humans; Hyperemia; Myocardial Perfusion Imaging; Perfusion; Positron-Emission Tomography; Purines; Pyrazoles; Water | 2022 |
Rapid rest/stress regadenoson ungated perfusion CMR for detection of coronary artery disease in patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Female; Heart Rate; Humans; Hyperemia; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Vasodilator Agents | 2017 |
Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
Topics: Adenosine; Aged; Caffeine; Coffee; Coronary Artery Disease; Coronary Circulation; Female; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Vasodilator Agents | 2017 |
Use of regadenoson for measurement of fractional flow reserve.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Cardiac Catheterization; Coronary Angiography; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Severity of Illness Index; Vasodilator Agents | 2014 |
Variability of fractional flow reserve according to the methods of hyperemia induction.
Topics: Adenosine; Aged; Coronary Artery Disease; Coronary Circulation; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Purines; Pyrazoles; Radiography; Reproducibility of Results; Vasodilator Agents | 2015 |
Regadenoson versus dipyridamole hyperemia for cardiac PET imaging.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Dipyridamole; Female; Heart Diseases; Hemodynamics; Humans; Hyperemia; Male; Middle Aged; Positron-Emission Tomography; Purines; Pyrazoles; Vasodilator Agents | 2015 |
Capturing maximal coronary vasodilation for myocardial perfusion imaging: is timing everything?
Topics: Adenosine A2 Receptor Agonists; Dipyridamole; Humans; Hyperemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilation; Vasodilator Agents | 2015 |
Regadenoson-induced hyperemia for absolute myocardial blood flow quantitation by
Topics: Allografts; Ammonia; Coronary Circulation; Humans; Hyperemia; Nitrogen Radioisotopes; Purines; Pyrazoles | 2017 |
Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dogs; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Connectivity of radiotracers to vasodilators is thallium the missing link?
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Dogs; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |